{
  "ptid_time": "037_S_4028_2013-05-07",
  "img_path": "/data/qiuhui/data/adni/images/037_S_4028/2013-05-07/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 9,633 mm³, 56.9% below the reference mean. With a Z-score of -1.42 (7.7th percentile), this represents mild atrophy; hippocampal volume measures 6,429 mm³, 16.3% below the reference mean. With a Z-score of -1.83 (3.3th percentile), this represents moderate atrophy; whole brain volume measures 992,993 mm³, 3.5% below the reference mean. With a Z-score of -0.44 (33.1th percentile), this represents normal volume ; entorhinal cortex volume measures 3,240 mm³, 16.8% below the reference mean. With a Z-score of -1.30 (9.7th percentile), this represents mild atrophy; fusiform gyrus volume measures 18,643 mm³, 2.4% above the reference mean. With a Z-score of 0.27 (60.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 18,592 mm³, 9.4% below the reference mean. With a Z-score of -0.83 (20.2th percentile), this represents normal volume . ",
  "text_data": "Age is 65.5 years. Gender is Female. Education: 18 years. MMSE: 30.0. MoCA: 29.0. Logical Memory: 18.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.06 SUVR (normal ); Total tau: 329.60 pg/mL (mild elevated); Phosphorylated tau: 26.55 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows mild to moderate atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, and ventricles), but cognitive scores (MMSE 30, MoCA 29) are intact, and biomarkers (normal P-tau, AV45) do not strongly support active neurodegeneration. The absence of APOE4 and normal amyloid further reduce Alzheimer's likelihood.  \n**Diagnosis:** **CN (Cognitively Normal)**  \n**Confidence:** **Medium** (Atrophy may reflect early aging or preclinical changes, but clinical and biomarker data do not yet meet MCI/dementia criteria.)",
  "timestamp": "2025-07-26T06:39:31.579469"
}